IMBRUVICA® HCP US
HCP WAVE Campaign
IMBRUVICA® leads the hematology oncology category with results that are hard to surpass by its competitors. Upon the NCCN recommendation for 1L therapy for CLL patients, a campaign update was in call for. The visual response to such challenge was the creation of a tidal wave made of millions of clinical studies which support that recommendation.
Leading the Way
As a leader in the market, IMBRUVICA® has the experience and evidence to stand above its competitors with confidence. A tidal wave of clinical studies proves its superiority and it’s a quick analogy to where the brand stands.
Campaign Pull-Through
“The wave” campaign was pulled-through journal ads, HCP websites, digital visits, banners, emails and convention tactics.
